Adverse effects of immunoglobulin therapy

Y Guo, X Tian, X Wang, Z **ao - Frontiers in immunology, 2018 - frontiersin.org
Immunoglobulin has been widely used in a variety of diseases, including primary and
secondary immunodeficiency diseases, neuromuscular diseases, and Kawasaki disease …

[HTML][HTML] Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention

DD Patel, JB Bussel - Journal of Allergy and Clinical Immunology, 2020 - Elsevier
The humoral immune response provides specific, long-lived protection against invading
pathogens, via immunoglobulin production and other memory functions. IgG, the most …

Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity

A Bodansky, JL David, A Rallistan, M Kalaycioglu… - The Journal of clinical …, 2024 - jci.org
Given the global surge in autoimmune diseases, it is critical to evaluate emerging
therapeutic interventions. Despite numerous new targeted immunomodulatory therapies …

Affinity of human IgG subclasses to mouse Fc gamma receptors

G Dekkers, AEH Bentlage, TC Stegmann, HL Howie… - MAbs, 2017 - Taylor & Francis
Human IgG is the main antibody class used in antibody therapies because of its efficacy and
longer half-life, which are completely or partly due to FcγR-mediated functions of the …

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study

P Kiessling, R Lledo-Garcia, S Watanabe… - Science translational …, 2017 - science.org
Pathogenic immunoglobulin G (IgG) autoantibodies characterize some human autoimmune
diseases; their high concentration and long half-life are dependent on recycling by the …

Strategies for glycoengineering therapeutic proteins

K Dammen-Brower, P Epler, S Zhu, ZJ Bernstein… - Frontiers in …, 2022 - frontiersin.org
Almost all therapeutic proteins are glycosylated, with the carbohydrate component playing a
long-established, substantial role in the safety and pharmacokinetic properties of this …

[HTML][HTML] Targeting FcRn for immunomodulation: benefits, risks, and practical considerations

HH Peter, HD Ochs, C Cunningham-Rundles… - Journal of Allergy and …, 2020 - Elsevier
The neonatal fragment crystallizable (Fc) receptor (FcRn) functions as a recycling
mechanism to prevent degradation and extend the half-life of IgG and albumin in the …

[HTML][HTML] Intravenous immunoglobulin (IVIG)

VB Arumugham, A Rayi - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the mechanism of action of intravenous immunoglobulin. Describe the
potential adverse effects of intravenous immunoglobulin. Review the appropriate monitoring …

Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases

E Chalayer, B Gramont, F Zekre… - Autoimmunity …, 2022 - Elsevier
Systemic autoimmune and inflammatory diseases have a complex and only partially known
pathophysiology with various abnormalities involving all the components of the immune …

Nonspecific orbital inflammation (NSOI): unraveling the molecular pathogenesis, diagnostic modalities, and therapeutic interventions

KY Wu, M Kulbay, P Daigle, BH Nguyen… - International Journal of …, 2024 - mdpi.com
Nonspecific orbital inflammation (NSOI), colloquially known as orbital pseudotumor,
sometimes presents a diagnostic and therapeutic challenge in ophthalmology. This review …